Programme



   ​  > Main Congress




          



 

 ​

 

 

 

  

  

 

This is a rare opportunity, where in the same room, you might have busy clinicians and academic leaders. You actually start to understand how this all works together - and that's where you get the excitement, where there's understanding that bringing academic medicine to a busy clinical setting ultimately really distinguishes the healthcare delivery.                 

 

 

 

 

 

 

 

Prof Mary Klotman  
Dean, Duke University School of Medicine, USA

 


 
 
Programme >
 

Oncology, and Cancer and Stem Cell Biology Symposium
Fighting Against Cancer: Short Talk


 Track type: Symposium


Date: 17 Sep 2021

 

 Time: 1640 - 1710


Location: Seminar Room 5



This symposium will showcase the latest research developed in the National Cancer Centre Singapore (NCCS) and the Cancer and Stem Cell Biology Programme (CSCB) at the Duke-NUS Medical School Singapore. This sharing aims to build collaborations and exchange of ideas to advance research for patient care.





TOPIC 1:

                             
STARLIGHT Initiative – Sarcoma and Rare Cancers in the Light



TOPIC 2:

                                
Estimating Rates of Stochastic Phenotype Transitions in Heterogeneous Cell Populations


 

Speaker: Dr Narendra Suhas Jagannathan

                                                 




                          

TOPIC 3:

                                                        
Trajectory Analysis of Single Cell RNAseq Identifies Factors Involved in Immune Escape in Squamous Cell Cancers


 

Speaker: Dr Quah Hong Sheng

 




TOPIC 4:


Structural Basis of WLS/Evi-Mediated Wnt Transport and Secretion


 

Speaker: Dr Yu Jia

                                                 




TOPIC 5:

                                                                          
Mutant p110α-dependent Co-option of Wild-type p110α as a Novel Oncogenic Mechanism

Speaker: Dr Wang Chao
                                            


TOPIC 6:        

    KRAS Regulation of TAZ Stability in Cancer Stem Cells
                                     



                                                   


 
*Information is correct at time of update
 
 








Disclaimer